Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Presentation Miami Valves 2025

Septal Occluders: Not just for the intra-atrial septum

Presenter: John M. Lasala

January 30, 2025

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Conference News NY Valves 2024

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Michael O'Riordan

June 06, 2024

Presentation Miami Valves 2024

First-in-man use of ELECTROSURGICAL SESAME (SEptal Scoring Along the Midline Endocardium) for the management of subaortic stenosis

Presenter: Cristina Sanina

February 01, 2024

News Conference News TCT 2021

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Michael O'Riordan

October 07, 2021

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

News Daily News

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Shelley Wood

April 13, 2020

Presentation TCT Abstracts Posters 2019

Retrograde Transcatheter Closure Of Perimembranous Aneurysmal Ventricular Septal Defects Using Amplatzer Vascular Plug II

Presenter: Rania Bushokka

October 10, 2019

News Opinion Fellow Talk

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Yashasvi Chugh, MD

August 05, 2019

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

News Daily News

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Yael L. Maxwell

January 11, 2019

Presentation TVT 2017

Percutaneous Use of Septal Occluder for Management of Aortic Insufficiency Post-Left Ventricular Assist Device

Presenter: Shigeru Saito, Jonathon M. White, Sidakpal Panaich, MD

June 16, 2017

Presentation TVT 2017

Techniques for Trans-septal Valve-in-Ring, Valve-in-Valve, and Valve-in-MAC

Presenter: Brian K. Whisenant, Mayra Guerrero

June 15, 2017

News Daily News

Shunts Intracardíacos Post-TAVR: Raras pero Potencialmente Letales

Todd Neale

November 28, 2016

News Daily News

Intracardiac Shunts After TAVR: Rare but Potentially Lethal

Todd Neale

November 28, 2016

Presentation TVT 2016

TVT 1071: Reduction of Left Ventricular Outflow Gradient in the Context of Septal Hypertrophy With Transcatheter Mitral Valve Repair

Presenter: Megan Coylewright, MD

June 16, 2016

Presentation TVT 2016

TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM

Presenter: Yoshifumi Nakajima, MD

June 16, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

Advertisement

Septal Occluders: Not just for the intra-atrial septum

August 2024 Dispatch for the CV Team

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

First-in-man use of ELECTROSURGICAL SESAME (SEptal Scoring Along the Midline Endocardium) for the management of subaortic stenosis

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Retrograde Transcatheter Closure Of Perimembranous Aneurysmal Ventricular Septal Defects Using Amplatzer Vascular Plug II

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Percutaneous Use of Septal Occluder for Management of Aortic Insufficiency Post-Left Ventricular Assist Device

Techniques for Trans-septal Valve-in-Ring, Valve-in-Valve, and Valve-in-MAC

Shunts Intracardíacos Post-TAVR: Raras pero Potencialmente Letales

Intracardiac Shunts After TAVR: Rare but Potentially Lethal

TVT 1071: Reduction of Left Ventricular Outflow Gradient in the Context of Septal Hypertrophy With Transcatheter Mitral Valve Repair

TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content